My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    The future of artemisinins: natural, synthetic or recombinant?

    Hommel M.

    J Biol. 2008 Dec 15;7(10):38. Review.PMID: 19090980 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid.

    Ro DK, Ouellet M, Paradise EM, Burd H, Eng D, Paddon CJ, Newman JD, Keasling JD.

    BMC Biotechnol. 2008 Nov 4;8:83.PMID: 18983675 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Production of the antimalarial drug precursor artemisinic acid in engineered yeast.

    Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, Keasling JD.

    Nature. 2006 Apr 13;440(7086):940-3.PMID: 16612385 [PubMed - indexed for MEDLINE]Related articles

    4.

    Artemisinins: activities and actions.

    Haynes RK, Krishna S.

    Microbes Infect. 2004 Nov;6(14):1339-46. Review.PMID: 15555542 [PubMed - indexed for MEDLINE]Related articles

    5.

    Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!

    Mutabingwa TK.

    Acta Trop. 2005 Sep;95(3):305-15. Review.PMID: 16098946 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recent advances in artemisinin production through heterologous expression.

    Arsenault PR, Wobbe KK, Weathers PJ.

    Curr Med Chem. 2008;15(27):2886-96. Review.PMID: 18991643 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon.

    Sayang C, Gausseres M, Vernazza-Licht N, Malvy D, Bley D, Millet P.

    Malar J. 2009 Jul 29;8:176.PMID: 19640292 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.

    White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP.

    Malar J. 2009 Nov 11;8:253.PMID: 19906307 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Therapy of uncomplicated malaria in children: a review of treatment principles, essential drugs and current recommendations.

    Deen JL, von Seidlein L, Dondorp A.

    Trop Med Int Health. 2008 Sep;13(9):1111-30. Epub 2008 Jul 24. Review.PMID: 18657092 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Artemisinins.

    Woodrow CJ, Haynes RK, Krishna S.

    Postgrad Med J. 2005 Feb;81(952):71-8. Review.PMID: 15701735 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.

    O'Neill PM.

    Expert Opin Investig Drugs. 2005 Sep;14(9):1117-28. Review.PMID: 16144496 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

    Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

    Malar J. 2009 Jan 5;8:2.PMID: 19123926 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Control of malaria: market for artemisinin and its derivatives]

    Pilloy J.

    Med Trop (Mars). 2006 Dec;66(6):554-7. French. PMID: 17286020 [PubMed - indexed for MEDLINE]Related articles

    14.

    An affordable antimalarial.

    Tenenbaum DJ.

    Environ Health Perspect. 2004 Jan;112(1):A25. No abstract available. PMID: 14714543 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Clinical Pharmacology of Antimalarial Drugs--First AHRO International Malaria Symposium.

    Kurtzhals J.

    IDrugs. 2008 Oct;11(10):713-5. No abstract available. PMID: 18828068 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Active agents and resistance mechanisms. Medicinal Chemistry of drugs against malaria]

    Schlitzer M.

    Pharm Unserer Zeit. 2009;38(6):512-20. Review. German. No abstract available. PMID: 19862719 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of anti-malarial drugs in eliminating malaria.

    White NJ.

    Malar J. 2008 Dec 11;7 Suppl 1:S8. Review.PMID: 19091042 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Infectious diseases. Source of new hope against malaria is in short supply.

    Enserink M.

    Science. 2005 Jan 7;307(5706):33. No abstract available. PMID: 15637249 [PubMed - indexed for MEDLINE]Related articles

    19.

    Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.

    Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG.

    Malar J. 2008 Dec 11;7 Suppl 1:S7. Review.PMID: 19091041 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    IV artesunate for severe malaria.

    [No authors listed]

    Med Lett Drugs Ther. 2008 May 19;50(1286):37. No abstract available. PMID: 18487956 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk